We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNMC.L Regulatory News (NMC)

  • There is currently no data for NMC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)- NMC Health plc AMENDMENT

18 Feb 2020 14:16

RNS Number : 3740D
JPMorgan Securities Plc
18 February 2020
 

AMENDMENT

INCREASED EQUITY PURCHASES BY 4,334 TO 3,938,561

INCREASED EQUITY SALES BY 4,173 TO 3,223,927

INCREASED CONVERTIBLE BOND PURCHASES BY 2,200,000 TO 6,800,000

INCREASED CONVERTIBLE BOND SALES BY 1,800,000 TO 5,600,000

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

NMC Health plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Corporate Broker & Financial Adviser to NMC Health.

(d) Date dealing undertaken:

10 February 2020

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

(GBP)

Lowest price per unit paid/received

(GBP)

Ordinary Shares

Purchase

 

Sale

3,938,561

 

3,223,927

9.2620

 

9.2620

7.1780

 

7.1720

 

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Convertible Bond

 

Purchase

 

Sale

6,800,000

 

5,600,000

82.5500 USD

 

83.0000 USD

80.0000 USD

 

81.5000 USD

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Ordinary Shares

Equity Swap

Long

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Short

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

17,501

3,111

4,392

5,576

473

3,624

4,305

297

5,721

107,781

990

4,290

13,507

1,697

121,080

50,985

2,939

15,378

30,977

4,726

21,000

13,622

28,351

105,067

11,390

284,588

 

22,256

10,585

5,352

131

641

1,618

137

104,343

105,475

803

145

817

11,766

6,400

9,552

145

2,653

328,642

5,265

79,864

107,960

63

8,600

387

332,014

5,841

1,145

391

900

359

22,658

121,920

337,236

7.4364 GBP

7.4816 GBP

7.5850 GBP

7.5942 GBP

7.5945 GBP

7.6053 GBP

7.6148 GBP

7.6280 GBP

7.6314 GBP

7.6407 GBP

7.6656 GBP

7.6673 GBP

7.7148 GBP

7.7583 GBP

7.9356 GBP

8.0000 GBP

8.5127 GBP

8.5216 GBP

8.6366 GBP

8.6528 GBP

8.8861 GBP

8.9222 GBP

9.2615 GBP

9.2618 GBP

9.2619 GBP

9.2620 GBP

 

7.4013 GBP

7.4667 GBP

7.4736 GBP

7.4782 GBP

7.5147 GBP

7.5199 GBP

7.5261 GBP

7.5455 GBP

7.5741 GBP

7.5795 GBP

7.5900 GBP

7.5981 GBP

7.6347 GBP

7.7060 GBP

7.7104 GBP

7.7262 GBP

7.7668 GBP

7.8072 GBP

7.8190 GBP

7.8598 GBP

7.8631 GBP

7.8900 GBP

7.9202 GBP

8.0022 GBP

8.0195 GBP

8.1559 GBP

8.4193 GBP

8.5463 GBP

8.5792 GBP

8.6503 GBP

9.0758 GBP

9.2620 GBP

9.2621 GBP

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

18 February 2020

Contact name:

Alwyn Basch

Telephone number:

020 7742 7407

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEREALAPFFSEEFA
Date   Source Headline
27th Apr 202012:40 pmRNSHolding(s) in Company
27th Apr 20207:55 amRNSCancellation of Listing
22nd Apr 20206:10 pmRNSNMC Health
22nd Apr 202010:20 amRNSHolding(s) in Company
22nd Apr 202010:15 amRNSHolding(s) in Company
21st Apr 20207:00 amRNSHolding(s) in Company
21st Apr 20207:00 amRNSHolding(s) in Company
21st Apr 20207:00 amRNSHolding(s) in Company
17th Apr 202012:40 pmRNSHolding(s) in Company
16th Apr 20206:00 pmRNSNMC Health
16th Apr 202010:05 amRNSAdditional Board Disclosures
14th Apr 20207:00 amRNSBoard Changes
9th Apr 20206:35 pmRNSNMC Health
9th Apr 20202:30 pmRNSAlvarez & Marsal appointed as administrators
8th Apr 20204:30 pmRNSHoldings in Company
8th Apr 20203:09 pmRNSStatement re. administration application by ADCB
6th Apr 20204:30 pmRNSHoldings in Company
6th Apr 20207:00 amRNSStatement regarding Abu Dhabi Commercial Bank
3rd Apr 20209:30 amRNSHoldings in Company
26th Mar 20204:09 pmRNSBoard Changes
25th Mar 20206:20 pmRNSNMC Health
25th Mar 202012:30 pmRNSHoldings in Company
25th Mar 202012:30 pmRNSHoldings in Company
25th Mar 202012:30 pmRNSHoldings in Company
24th Mar 20209:46 amRNSUpdate on financial position
23rd Mar 202010:00 amRNSHoldings in Company
17th Mar 20206:30 pmRNSNMC Health
13th Mar 20206:27 pmRNSNMC Health
12th Mar 20208:31 amRNSUpdate regarding independent review
10th Mar 20204:11 pmRNSUpdate on financial position
10th Mar 20203:20 pmRNSForm 8.3 - NMC Health plc
10th Mar 202010:55 amRNSForm 8.5 (EPT/RI) - NMC Health plc
9th Mar 20205:51 pmRNSForm 8.5 (EPT/RI) - Amendment
9th Mar 20204:18 pmRNSStatement regarding NMC Health plc
9th Mar 20202:21 pmRNSForm 8.3 - NMC Health PLC
9th Mar 202012:21 pmRNSForm 8.3 - NMC Health plc
9th Mar 202012:16 pmRNSForm 8.3 - NMC Health plc
9th Mar 202012:15 pmRNSForm 8.3 - NMC Health plc
9th Mar 202012:07 pmRNSForm 8.3 - NMC Health plc
9th Mar 202012:05 pmRNSForm 8.3 - NMC Health plc
9th Mar 202012:02 pmRNSForm 8.3 - NMC Health plc
9th Mar 202011:52 amRNSForm 8.3 - NMC Health plc
9th Mar 202011:49 amRNSForm 8.3 - NMC Health plc
9th Mar 202011:45 amRNSForm 8.3 - NMC Health plc
9th Mar 202011:44 amRNSForm 8.3 - NMC Health plc
9th Mar 202011:37 amRNSForm 8.3 - NMC Health plc
6th Mar 20203:20 pmRNSForm 8.3 - NMC Health plc
6th Mar 20203:20 pmGNWDavidson Kempner Capital Management LP : Form 8.3 - NMC Health plc
6th Mar 20202:26 pmRNSStatement regarding major shareholdings
6th Mar 202011:43 amRNSForm 8.3 - NMC Health plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.